Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.95+0.01 (+1.29%)
Close on Nov 17, 2026Market cap $11.21MP/E –Yield –
Bionano Genomics total assets
Total assets on the balance sheet at the end of each period.
Bionano Genomics's total assets was $47.59M at Jun 30, 2026. For fiscal 2025 it was $73.58M, down 4.0% from the year before. The highest annual figure on record is $377.10M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.58M | -4.0% |
| FY2024 | Dec 31, 2024 | $76.67M | -64.2% |
| FY2023 | Dec 31, 2023 | $214.40M | -30.3% |
| FY2022 | Dec 31, 2022 | $307.50M | -18.5% |
| FY2021 | Dec 31, 2021 | $377.10M | +523.8% |
| FY2020 | Dec 31, 2020 | $60.45M | +100.1% |
| FY2019 | Dec 31, 2019 | $30.21M | +21.8% |
| FY2018 | Dec 31, 2018 | $24.80M | +144.5% |
| FY2017 | Dec 31, 2017 | $10.15M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $47.59M | -37.4% |
| Q1 FY2026 | Mar 31, 2026 | $64.80M | -17.4% |
| Q4 FY2025 | Dec 31, 2025 | $73.58M | -4.0% |
| Q3 FY2025 | Sep 30, 2025 | $79.06M | -9.5% |
| Q2 FY2025 | Jun 30, 2025 | $76.01M | -41.2% |
| Q1 FY2025 | Mar 31, 2025 | $78.41M | -50.4% |
| Q4 FY2024 | Dec 31, 2024 | $76.67M | -64.2% |
| Q3 FY2024 | Sep 30, 2024 | $87.36M | -52.0% |
| Q2 FY2024 | Jun 30, 2024 | $129.36M | -52.3% |
| Q1 FY2024 | Mar 31, 2024 | $158.00M | -45.9% |
| Q4 FY2023 | Dec 31, 2023 | $214.40M | -30.3% |
| Q3 FY2023 | Sep 30, 2023 | $181.90M | -43.8% |
| Q2 FY2023 | Jun 30, 2023 | $271.38M | -15.6% |
| Q1 FY2023 | Mar 31, 2023 | $292.15M | -16.1% |
| Q4 FY2022 | Dec 31, 2022 | $307.50M | -18.5% |
| Q3 FY2022 | Sep 30, 2022 | $323.70M | -10.0% |
| Q2 FY2022 | Jun 30, 2022 | $321.55M | -9.9% |
| Q1 FY2022 | Mar 31, 2022 | $348.21M | -9.5% |
| Q4 FY2021 | Dec 31, 2021 | $377.10M | +523.8% |
| Q3 FY2021 | Sep 30, 2021 | $359.66M | +768.8% |
| Q2 FY2021 | Jun 30, 2021 | $356.81M | +1211.6% |
| Q1 FY2021 | Mar 31, 2021 | $384.86M | +1914.8% |
| Q4 FY2020 | Dec 31, 2020 | $60.45M | +100.1% |
| Q3 FY2020 | Sep 30, 2020 | $41.40M | +115.5% |
| Q2 FY2020 | Jun 30, 2020 | $27.20M | +7.9% |
| Q1 FY2020 | Mar 31, 2020 | $19.10M | -35.4% |
| Q4 FY2019 | Dec 31, 2019 | $30.21M | +21.8% |
| Q3 FY2019 | Sep 30, 2019 | $19.21M | -37.4% |
| Q2 FY2019 | Jun 30, 2019 | $25.21M | +148.5% |
| Q1 FY2019 | Mar 31, 2019 | $29.55M | – |
| Q4 FY2018 | Dec 31, 2018 | $24.80M | – |
| Q3 FY2018 | Sep 30, 2018 | $30.67M | – |
| Q4 FY2017 | Dec 31, 2017 | $10.15M | – |
See a number that looks wrong?